Format
Sort by
Items per page

Send to

Choose Destination

Links from OMIM

Items: 1 to 20 of 29

1.

Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157. 1993.

Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ.

J Immunol. 2008 Nov 1;181(9):5817-27. No abstract available.

2.

Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency.

Speckmann C, Pannicke U, Wiech E, Schwarz K, Fisch P, Friedrich W, Niehues T, Gilmour K, Buiting K, Schlesier M, Eibel H, Rohr J, Superti-Furga A, Gross-Wieltsch U, Ehl S.

Blood. 2008 Nov 15;112(10):4090-7. doi: 10.1182/blood-2008-04-153361. Epub 2008 Aug 26.

3.

Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.

LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM, Keegan AD, Garcia KC.

Cell. 2008 Jan 25;132(2):259-72. doi: 10.1016/j.cell.2007.12.030.

4.

Interleukin-21: a new modulator of immunity, infection, and cancer.

Brandt K, Singh PB, Bulfone-Paus S, Rückert R.

Cytokine Growth Factor Rev. 2007 Jun-Aug;18(3-4):223-32. Epub 2007 May 16. Review.

PMID:
17509926
5.

Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.

Wang X, Rickert M, Garcia KC.

Science. 2005 Nov 18;310(5751):1159-63.

6.

Gene therapy insertional mutagenesis insights.

Davé UP, Jenkins NA, Copeland NG.

Science. 2004 Jan 16;303(5656):333. No abstract available.

7.

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.

Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M.

N Engl J Med. 2002 Apr 18;346(16):1185-93.

8.

Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway.

Lamaze C, Dujeancourt A, Baba T, Lo CG, Benmerah A, Dautry-Varsat A.

Mol Cell. 2001 Mar;7(3):661-71.

9.

Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex.

Asao H, Okuyama C, Kumaki S, Ishii N, Tsuchiya S, Foster D, Sugamura K.

J Immunol. 2001 Jul 1;167(1):1-5.

10.
11.

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A.

Science. 2000 Apr 28;288(5466):669-72.

12.

Interleukin-2 signaling and inherited immunodeficiency.

Cacalano NA, Johnston JA.

Am J Hum Genet. 1999 Aug;65(2):287-93. Review. No abstract available.

13.

Mutations in the gene for the common gamma chain (gammac) in X-linked severe combined immunodeficiency.

Fugmann SD, Müller S, Friedrich W, Bartram CR, Schwarz K.

Hum Genet. 1998 Dec;103(6):730-1.

PMID:
9921912
14.

An interleukin-2 receptor gamma chain mutation with normal thymus morphology.

Sharfe N, Shahar M, Roifman CM.

J Clin Invest. 1997 Dec 15;100(12):3036-43.

15.

B-cell-negative severe combined immunodeficiency associated with a common gamma chain mutation.

Jones AM, Clark PA, Katz F, Genet S, McMahon C, Alterman L, Cant A, Kinnon C.

Hum Genet. 1997 May;99(5):677-80.

PMID:
9150740
16.

Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.

Stephan V, Wahn V, Le Deist F, Dirksen U, Broker B, Müller-Fleckenstein I, Horneff G, Schroten H, Fischer A, de Saint Basile G.

N Engl J Med. 1996 Nov 21;335(21):1563-7. No abstract available.

17.
18.

Characterization of the human interleukin-2 receptor gamma chain gene.

Noguchi M, Adelstein S, Cao X, Leonard WJ.

J Biol Chem. 1993 Jun 25;268(18):13601-8.

19.

The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.

Puck JM, Deschênes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, Henthorn PS.

Hum Mol Genet. 1993 Aug;2(8):1099-104.

PMID:
8401490
20.

Supplemental Content

Support Center